Sanbio Stock Price, News & Analysis
Company Description
Sanbio (OTC Link: SNBOY) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $394.6M.
SNBOY stock has gained 17.9% over the past year.
This page provides a comprehensive overview of SNBOY stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Sanbio (SNBOY) stock. Over the past 12 months, the stock has gained 17.9%. At a market capitalization of $394.6M, SNBOY is classified as a small-cap stock with approximately 78.0M shares outstanding.
Latest News
Sanbio has 5 recent news articles. Key topics include partnership. View all SNBOY news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
SNBOY Company Profile & Sector Positioning
Sanbio (SNBOY) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing SNBOY often look at related companies in the same sector, including Northwest Bio (NWBO), Cytodyn Inc (CYDY), Clinuvl Phrmaceu (CLVLY), Nxera Pharma (SOLTF), and Oxford Biomedica (OXBDF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate SNBOY's relative position within its industry.